Stock Information
Generate Biomedicines Inc (GENB)
Ticker Symbol: GENB
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,774.18 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): N/A
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: N/A%
Latest News
-
Zealand Pharma pens $1.2bn AI obesity drug discovery pact with Generate
Wed, Oct 14, 2026 4:17 PM
-
Generate Biomedicines Lands Major AI Drug Partnership to Target Booming Obesity Market
Wed, Oct 14, 2026 3:30 PM
-
Generate Biomedicines: Zealand Deal For Obesity Programs May Not Be Quite What It Seems
Wed, Oct 14, 2026 1:13 PM
-
Generate Biomedicines and Zealand Pharma Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Tue, Oct 13, 2026 8:30 PM
-
Zealand Pharma and Generate Biomedicines Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with AI for Metabolic Diseases
Tue, Oct 13, 2026 8:30 PM
-
Generate Biomedicines To Receive $30M Upfront, Up To $1.2B In Milestones And Tiered Royalties Under Zealand Pharma Collaboration
Tue, Oct 13, 2026 4:34 PM
-
'Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion' - Bloomberg
Tue, Oct 13, 2026 4:15 PM
-
Prologue Medicines Appoints Stephen Harrison, Ph.D., as Chief Scientific Officer
Tue, Oct 13, 2026 2:00 PM
-
Generate Biomedicines: The Dosing Interval Is The Moat, Not The Algorithm
Tue, Oct 13, 2026 7:13 AM
Key Financials
Financial data not available
